Nav: Home

Researchers find moderate vascular risk in southwest native population

April 21, 2016

Brooklyn, NY - In a newly published, pilot study in the journal Ethnicity & Disease, researchers report a relatively low prevalence of vascular risk among participants of the Southwest Heart Mind Study, especially among those treated for hypertension and hyperlipidemia despite overweight and obesity.

Researchers Deborah Gustafson, PhD, MS, and Francine Gachupin, PhD, MPH, led the research team comprising both academic researchers and tribal program personnel. The research results were gained from culturally fair instruments and the collection of several biomarkers (physical measurements, blood chemistries, etc.). The research identified cognitive and depressive symptoms as well as cardiovascular, lifestyle, and demographic factors of 37 Southwest Tribal elders aged 55 years and older.

Dr. Gustafson is professor of neurology at SUNY Downstate Medical Center and Dr. Gachupin is assistant director of the University of Arizona Cancer Center's Cancer Health Disparities Program and the Native American Research and Training Center.

The researchers note that American Indian and Alaska Native (AIAN) communities in the United States are aging; the older AIAN population (Non-Hispanic and Hispanic) was 212,605 in 2007 and is projected to reach almost 918,000 by 2050. The Southwest US is home to most AI communities. Accompanying aging is a profound increase in vascular and metabolic diseases - many due to obesity. Among AIANs, the study team expects to identify 23,850 persons age 65 years and older as having had dementia in 2010, a number they expect to increase to 100,980 by 2050.

The researchers conducted a pilot survey, the Southwest Heart Mind Study (SHMS), to ascertain the feasibility of assessing cognitive and depressive symptoms, and cardiovascular, lifestyle, and demographic factors. They measured demographic, social network, and risk factor surveys; tests of cognition, depression and anxiety; physical measurements; blood biochemistries; and APOE genotyping. The Southwest Tribe within the study is from the Albuquerque Area (AA) of the Indian Health Service. At the time of this survey there were 19% (16,293/86,000) of individuals age 50 years and older in the AA. These pilot data form the basis for future investigations.
The article is published in the spring 2016 issue of Ethnicity & Disease, a scholarly journal dedicated to publishing research on the causal and the associative relationships of disease among ethnic populations. The SHMS was supported by the National Institutes of Health, Native American Research Centers for Health (NARCH) U26 IHS 300287/01. An abstract of the article is available at: .

Researcher Contact Information

Deborah Gustafson, PhD;, (347) 536-4865

Francine Gachupin, PhD;, (520) 621-5072

About SUNY Downstate Medical Center

Founded in 1860, SUNY Downstate Medical Center was the first medical school in the United States to bring teaching out of the lecture hall and to the patient's bedside. A center of innovation and excellence in research and clinical service delivery, SUNY Downstate comprises a College of Medicine, Colleges of Nursing and Health Related Professions, a School of Graduate Studies, a School of Public Health, University Hospital of Brooklyn, and a multifaceted biotechnology initiative including the Downstate Biotechnology Incubator and BioBAT for early-stage and more mature companies, respectively. SUNY Downstate ranks twelfth nationally in the number of alumni who are on the faculty of American medical schools. More physicians practicing in New York City have graduated from SUNY Downstate than from any other medical school. For more information, visit:

About the University of Arizona Health Sciences

The University of Arizona Health Sciences is the statewide leader in biomedical research and health professions training. The UA Health Sciences includes the UA Colleges of Medicine (Phoenix and Tucson), Nursing, Pharmacy and Mel and Enid Zuckerman College of Public Health, with main campus locations in Tucson and the growing Phoenix Biomedical Campus in downtown Phoenix. From these vantage points, the UA Health Sciences reaches across the state of Arizona and the greater Southwest to provide cutting-edge health education, research, patient care and community outreach services. A major economic engine, the UA Health Sciences employs almost 5,000 people, has nearly 1,000 faculty members and garners more than $126 million in research grants and contracts annually. For more information:

SUNY Downstate Medical Center

Related Depressive Symptoms Articles:

Columbia and Harvard researchers find yoga and controlled breathing reduce depressive symptoms
A new study demonstrated that individuals with major depressive disorder had a significant reduction in depressive symptoms during a 12-week integrative health intervention that included Iyengar yoga classes and coherent breathing.
Circadian light may relieve depressive symptoms in stroke rehab patients
Circadian lighting should be considered as part of rehabilitation unit environments, researchers said.
Survey: Significant number of airline pilots report depressive symptoms, suicidal thoughts
Hundreds of commercial airline pilots currently flying may be clinically depressed, according to an anonymous survey of nearly 1,850 pilots conducted by researchers at Harvard T.H.
What comes before new-onset major depressive disorder in kids, teens?
Early-onset major depressive disorder (MDD) is common in individuals with a family risk of depression.
Study shows low vitamin D levels are associated with increased negative and depressive symptoms in psychotic disorders
New research presented at this year's International Early Psychosis Association meeting in Milan, Italy (Oct.
Group activities reduced depressive symptoms among older people with dementia
Both a high-intensity functional exercise programme and a non-exercise group activity, conducted among older care facility residents with dementia, reduced high levels of depressive symptoms.
Mindfulness-based cognitive therapy linked to reduced depressive relapse risk
Mindfulness-based cognitive therapy was associated with a reduced risk of depressive relapse over a 60-week follow-up period compared with usual care and outcomes were comparable to those who received other active treatments, according to an article published online by JAMA Psychiatry.
Mindfulness-based cognitive therapy linked to reduced depressive relapse risk
The largest meta-analysis so far of Mindfulness-Based Cognitive Therapy (MBCT) for recurrent depression has found that MBCT is an effective treatment option that can help prevent the recurrence of major depression.
Calcium waves in the brain alleviate depressive behavior in mice
Researchers at the RIKEN Brain Science Institute in Japan have discovered that the benefits of stimulating the brain with direct current come from its effects on astrocytes -- not neurons -- in the mouse brain.
Rat problems in poor neighborhoods linked to depressive symptoms
Residents of Baltimore's low-income neighborhoods who believe rats are a big problem where they live are significantly more likely to suffer from depressive symptoms such as sadness and anxiety, new Johns Hopkins Bloomberg School of Public Health research suggests.

Related Depressive Symptoms Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...